Diagnostic value of cone-beam CT in histologically confirmed otosclerosis
Balázs Liktor +5 more
openalex +2 more sources
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath +13 more
wiley +1 more source
A New Approach for Estimating Liver IVIM Fast Diffusion Coefficient in Two-Compartment Model and Fast Diffusion Fraction in Three-Compartment Model: Theory and In Vivo Validation of Two Centers' Data. [PDF]
Ma FZ, Wáng YXJ.
europepmc +1 more source
YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy +9 more
wiley +1 more source
Revisiting the excess volatility puzzle through the lens of the Chiarella model. [PDF]
Kurth JG, Majewski AA, Bouchaud JP.
europepmc +1 more source
The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer [PDF]
J. Alexieva-Figusch +4 more
openalex +1 more source
Emerging role of ARHGAP29 in melanoma cell phenotype switching
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster +3 more
wiley +1 more source
<p>Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia</p>
Marta Masternak +17 more
openalex +2 more sources

